The International Association for Regenerative Therapy (IART) set to launch in Fall 2019
The HHPF Board is pleased to announce the creation of a new aligned organization, the “International Association for Regenerative Therapy” (IART). IART was created to sustain and expand regenerative medicine treatments such as prolotherapy and is set to launch this fall!
The current IART Board includes; Annette Zaharoff, MD, serving as President; Adam Balin, MD, Treasurer; and Martin Gallagher, MD, Vice President. IART will serve as an independent organization yet remain aligned with HHPF. IART will focus on education and training while HHPF will focus on service and other philanthropic endeavors to advance the treatment of chronic pain. We wish to maintain the passion and values that have made HHPF such an inviting organization.
IART is a professional membership organization whose mission is to teach globally, offer educational training, provide mentorship and networking opportunities, and advocate for increased availability of regenerative therapies. An inclusive membership structure will be open to health care providers, individuals or organizations interested in practicing, learning, teaching, researching and supporting prolotherapy and other regenerative therapies.
Our next major step is to launch our membership which includes several membership categories along with the opportunity to become a founding member. More information on membership is coming soon! We will keep you informed about IART’s launch.
This is an incredibly exciting effort and there are many details that still need to be finalized. We are grateful for HHPF’s support and look forward to sharing the message of both organizations with others.
HHPF joined the European School of Prolotherapy in its medical mission to treat patients in under-served communities on the Greek island of Crete. Farmers, laborers and other community members suffering from chronic pain received prolotherapy treatment during the week-long mission. In addition to treating patients, attendees participated in didactic lectures and demonstrations.
HHPF partnered with Pain School International to offer an interactive prolotherapy conference and workshop in Budapest, Hungary. Approximately 30 pain interventionists from around the globe attended the three-day conference which featured an evidence-based core curriculum using the HHPF Prolotherapy Procedural and Study Guides. Attendees participated in anatomically-based lectures and demonstrations, hands-on ultrasound-guided and fluoroscopy-guided injection instruction, palpation and marking workshops, and a cadaver lab with injection instruction.
HHPF past president David Rabago, MD, presented the abstracts of two prolotherapy studies as lectures at the elite North American Primary Care Research Group (NAPCRG) conference in Chicago, IL, in November 2018. Both won prestigious PEARL awards (https://www.napcrg.org/pearls); each was selected from among over 1000 peer-reviewed abstracts as those “most likely to influence clinical practice”.
The awards suggest that prolotherapy is gaining visibility in conventional (compared with alternative) medical venues. The HHPF is involved in both studies through funding (tennis elbow study) and collaboration (both studies). Principal investigators Michael Yelland (Australia) and Regina Sit (Hong Kong) have presented at the annual HHPF Prolotherapy Research Symposium; the manuscripts for both studies are in review with peer-reviewed journals.
The HHPF held our 50th prolotherapy service-learning trip in Honduras. Eighteen instructors and 27 learners at clinics in La Ceiba, Tela, and Olanchito treated over 1,500 patients during the two-week experience. In addition, the vein team treated approximately 1,000 patients for severe venous disease with ultrasound-guided foam sclerotherapy and two other devices for large varicosities. The ENT team performed 40 surgical procedures and distributed over 300 pairs of hearing aids to patients during their week-long service projects.